MDM2 protein expression is a negative prognostic marker in breast carcinoma. (Q38440364)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

MDM2 protein expression is a negative prognostic marker in breast carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Dmitry A Turbin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Chris D Bajdik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Karen A Gelmon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Erika Yorida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alessandro De Luca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Torsten O Nielsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

David G Huntsman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

69-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Regulation of p53 stability by Mdm2

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Functions of the MDM2 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

mdm2 expression is induced by wild type p53 activity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Interpreting and integrating risk factors for patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Nuclear beta-catenin in mesenchymal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Molecular classification of breast carcinomas using tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800484

7 January 2021

10.1038/MODPATHOL.3800484

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 January 2020

1046301350

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16258514%20AND%20SRC:MED&resulttype=core&format=json